ANSWER BEAUTY LIMITED – Trademark Portfolio
Entity Type: 99
ANSWER BEAUTY LIMITED owns a portfolio of 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as VDV, DOMIMI, DUEPAY, YJSTWXFP, and CANDY FROG. Of these, 6 are registered. The portfolio spans 5 Nice Classification classes, led by Class 28 (Toys & Sporting Goods) and Class 25 (Clothing). Headquartered in HK.
RM C 13/F HARVARD COMM BLDG,
105-111 THOMSON RD WAN CHAI,
HK 999077 , CN
Showing of trademarks Trademarks
Trademark Classifications
ANSWER BEAUTY LIMITED's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Frequently Asked Questions
How many trademarks does ANSWER BEAUTY LIMITED have?
ANSWER BEAUTY LIMITED has 6 U.S. trademarks filed with the USPTO. Of these, 6 registered.
What trademark classes does ANSWER BEAUTY LIMITED file in?
ANSWER BEAUTY LIMITED files trademarks across 5 Nice Classification classes. The most active classes are Class 28 (Toys & Sporting Goods), Class 25 (Clothing), Class 11 (Environmental Control), Class 21 (Housewares), Class 18 (Leather Goods). Class 28 covers games and playthings; gymnastic and sporting articles; decorations for christmas trees.
What are ANSWER BEAUTY LIMITED's most well-known trademarks?
ANSWER BEAUTY LIMITED's registered trademark portfolio includes well-known marks such as VDV, DOMIMI, DUEPAY, YJSTWXFP, and CANDY FROG. These are among 6 currently registered trademarks in the portfolio.
What is ANSWER BEAUTY LIMITED's trademark registration success rate?
ANSWER BEAUTY LIMITED has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.